Article info
PDFA difficult case
Longitudinally extensive spinal cord infarction in CADASIL
- Correspondence to Dr Stephan Hinze, Department of Neurology, Oxford University Hospitals NHS Trust, West Wing, Level 3, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK; Stephan.Hinze{at}gwh.nhs.uk
Citation
Longitudinally extensive spinal cord infarction in CADASIL
Publication history
- Accepted September 28, 2014
- First published October 16, 2014.
Online issue publication
April 14, 2016
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Impaired vasoreactivity in mildly disabled CADASIL patients
- Abnormal sensorimotor plasticity in CADASIL correlates with neuropsychological impairment
- Non-convulsive status epilepticus causing focal neurological deficits in CADASIL
- Non-convulsive status epilepticus causing focal neurological deficits in CADASIL
- Surgical repair following trauma to vascular graft causing spinal cord infarction
- Functional analysis of a recurrent missense mutation in Notch3 in CADASIL
- Non-convulsive status epilepticus causing focal neurological deficits in CADASIL
- Retinal abnormalities in CADASIL: a retrospective study of 18 patients
- Description of a simple test for CADASIL disease and determination of mutation frequencies in sporadic ischaemic stroke and dementia patients
- No association between multiple sclerosis and the Notch3 gene responsible for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)